Today: 30 June 2026
Carvana slips in thin year-end trade as Wall Street pares risk
29 December 2025
1 min read

Carvana slips in thin year-end trade as Wall Street pares risk

NEW YORK, December 29, 2025, 13:51 ET — Regular session

  • Carvana shares fell about 0.6% in afternoon trade, roughly in line with a broader dip in U.S. equities.
  • The stock is up about 116% year-to-date on a total-return basis.
  • Traders are watching year-end flows, Fed signals and the timing of Carvana’s next results.

Shares of Carvana Co. (CVNA) were down about 0.6% at $436.00 in afternoon trading on Monday, giving back early gains in a quiet, year-end market.

The pullback comes after a bruising run in 2025. Carvana has returned about 116% year-to-date on a total-return basis, according to Total Real Returns, leaving the stock sensitive to small shifts in risk appetite.

That sensitivity is in focus as the market heads into the final trading days of the year. Many money managers rebalance portfolios in late December, and high-momentum names can swing sharply on relatively light volume.

U.S. stocks also eased on Monday. “It’s a very light trading week ahead; volume is low,” said Sam Stovall, chief investment strategist at CFRA Research, in a Reuters market wrap, pointing to tax-loss harvesting — selling losing positions to offset gains.

Other auto retail names moved lower as well. CarMax (KMX) was down about 1%, while Lithia Motors (LAD) fell about 0.7%.

For Carvana, the latest catalyst has been renewed analyst attention. A weekend note highlighted the online used-car seller as a top pick among internet stocks for 2026, keeping the focus on how investors value companies exposed to disruption themes such as AI and autonomous vehicles, or self-driving cars, according to .

Even so, Monday’s move looked more tied to the tape than to fresh company news. Treasury yields eased and equities drifted lower, a backdrop that can weigh on high-beta stocks that have led the market higher.

What investors watch next is the company’s next earnings update and any clues on demand and financing trends. Carvana has not confirmed a date, but its next report is estimated for Feb. 18, 2026, after the close, according to .

Wall Street will be looking for updates on retail unit growth and profitability. Traders often focus on adjusted EBITDA — a company metric meant to show operating performance by stripping out interest, taxes and certain non-cash or one-time items.

Carvana traded between $429.00 and $440.00 on Monday, after ending the prior session at $438.47.

The company last reported quarterly results in late October, when it posted record third-quarter revenue of $5.65 billion and net income of $263 million, it said in a .

With the market entering the final stretch of 2025 and policy signals still in focus, traders said they expect choppy, headline-driven moves — and Carvana remains a stock that can exaggerate those swings.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386
Previous Story

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop